Status:
COMPLETED
Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocard...
Eligibility Criteria
Inclusion
- Outpatients \> =18 years of age with diagnosed clinically stable angina pectoris
Exclusion
- Patients with congestive heart failure, clinically significant cardiovascular disease, standing systolic blood pressure of less than 100mmHg, concomitant anti-anginal therapies similar to sublingual NTG
Key Trial Info
Start Date :
April 1 2001
Trial Type :
INTERVENTIONAL
End Date :
January 1 2005
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00143195
Start Date
April 1 2001
End Date
January 1 2005
Last Update
January 28 2021
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Athens, Attica, Greece, 11527
2
Pfizer Investigational Site
Athens, Greece, 123 51
3
Pfizer Investigational Site
Athens, Greece
4
Pfizer Investigational Site
Holargos/Athens, Greece, 11525